Breaking News Instant updates and real-time market news.

FL

Foot Locker

$71.78

0.43 (0.60%)

06:02
11/21/16
11/21
06:02
11/21/16
06:02

Foot Locker downgraded to Neutral from Overweight at Piper Jaffray

Piper Jaffray analyst Erinn Murphy downgraded Foot Locker to Neutral following the company's Q3 results. The stock is "priced for perfection" with the company at peak operating margins, Murphy tells investors in a research note. The analyst keeps a $72 price target for the shares. Foot Locker closed Friday up 43c to $71.78.

  • 30

    Nov

  • 01

    Dec

  • 05

    Dec

FL Foot Locker
$71.78

0.43 (0.60%)

11/01/16
WEDB
11/01/16
INITIATION
Target $80
WEDB
Outperform
Foot Locker initiated with an Outperform at Wedbush
Target $80.
11/02/16
WEDB
11/02/16
INITIATION
Target $80
WEDB
Outperform
Foot Locker initiated with an Outperform at Wedbush
Wedbush analyst Christopher Svezia initiated Foot Locker with an Outperform and a $80 price target.
11/02/16
11/02/16
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Alcoa (AA) initiated with a Neutral at Goldman and an Underperform at BofA/Merrill. 2. Everspin Technologies (MRAM) initiated with a Buy at Craig-Hallum, a Buy at Stifel, a Buy at Canaccord, and a Strong Buy at Needham. 3. Amazon.com (AMZN), Dick's Sporting (DKS), Foot Locker (FL), Finish Line (FINL), and Columbia Sportswear (COLM) were initiated with an Outperform at Wedbush while the firm initiated Nike (NKE) and DSW (DSW) with a Neutral. 4. FedEx (FDX) initiated with a Buy at Deutsche Bank while the firm initiated UPS (UPS) with a Hold. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/14/16
DBAB
11/14/16
NO CHANGE
Target $76
DBAB
Buy
Deutsche sees two risks heading into Foot Locker's results
Deutsche Bank analyst Paul Trussell highlights two risks into Foot Locker's earnings report: The stock being "well-liked and owned" after rallying 17% over the past three months with a low short interest of less than 10%, and the likely deceleration of same-store-sales in the second half of the quarter. Trussell, however, still sees long-term upside to earnings forecasts and upped his price target for the stock to $76 from $75. He reiterates a Buy rating on Foot Locker.

TODAY'S FREE FLY STORIES

PSTG

Pure Storage

$15.02

0.19 (1.28%)

05:55
09/22/17
09/22
05:55
09/22/17
05:55
Recommendations
Pure Storage analyst commentary  »

Pure Storage price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 11

    Dec

AABA

Altaba

$66.59

-0.33 (-0.49%)

, BABA

Alibaba

$177.39

-0.56 (-0.31%)

05:52
09/22/17
09/22
05:52
09/22/17
05:52
Recommendations
Altaba, Alibaba, Yahoo Japan analyst commentary  »

Altaba price target…

AABA

Altaba

$66.59

-0.33 (-0.49%)

BABA

Alibaba

$177.39

-0.56 (-0.31%)

YAHOY

Yahoo Japan

$8.90

-0.08 (-0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

REPYY

Repsol

$18.47

0.1 (0.54%)

05:52
09/22/17
09/22
05:52
09/22/17
05:52
Upgrade
Repsol rating change  »

Repsol upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSAR

Versartis

$21.60

-0.25 (-1.14%)

05:49
09/22/17
09/22
05:49
09/22/17
05:49
Downgrade
Versartis rating change  »

Versartis downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRPIF

BRP Inc.

05:48
09/22/17
09/22
05:48
09/22/17
05:48
Upgrade
BRP Inc. rating change  »

BRP Inc. upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$92.64

-1.76 (-1.86%)

05:47
09/22/17
09/22
05:47
09/22/17
05:47
Hot Stocks
Glass Lewis recommends Procter & Gamble holders vote for Nelson Peltz »

Trian Fund Management,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDXG

MiMedx

$12.27

-0.07 (-0.57%)

05:46
09/22/17
09/22
05:46
09/22/17
05:46
Recommendations
MiMedx analyst commentary  »

MiMedx shares offer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 13

    Nov

  • 14

    Nov

BA

Boeing

$256.04

0.58 (0.23%)

05:45
09/22/17
09/22
05:45
09/22/17
05:45
Hot Stocks
Boeing sees growing demand for new airplanes in Southeast Asia »

Boeing projects a demand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

05:45
09/22/17
09/22
05:45
09/22/17
05:45
General news
Breaking General news story  »

San Francisco Federal…

SSNI

Silver Spring

$16.15

0.01 (0.06%)

, ITRI

Itron

$75.85

-0.4 (-0.52%)

05:40
09/22/17
09/22
05:40
09/22/17
05:40
Downgrade
Silver Spring, Itron rating change  »

Silver Spring downgraded…

SSNI

Silver Spring

$16.15

0.01 (0.06%)

ITRI

Itron

$75.85

-0.4 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JUNO

Juno Therapeutics

$41.62

-3.59 (-7.94%)

05:38
09/22/17
09/22
05:38
09/22/17
05:38
Syndicate
Juno Therapeutics 6.1M share Secondary priced at $41.00 »

Morgan Stanley and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 22

    Sep

AA

Alcoa

$46.25

-1.25 (-2.63%)

05:38
09/22/17
09/22
05:38
09/22/17
05:38
Downgrade
Alcoa rating change  »

Alcoa downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOBE

Bob Evans

$77.29

-0.2 (-0.26%)

, POST

Post Holdings

$86.97

-0.39 (-0.45%)

05:38
09/22/17
09/22
05:38
09/22/17
05:38
Downgrade
Bob Evans, Post Holdings rating change  »

Bob Evans downgraded to…

BOBE

Bob Evans

$77.29

-0.2 (-0.26%)

POST

Post Holdings

$86.97

-0.39 (-0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$153.39

-2.68 (-1.72%)

05:36
09/22/17
09/22
05:36
09/22/17
05:36
Recommendations
Apple analyst commentary  »

Piper ups Apple target to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

TIF

Tiffany

$89.85

-0.08 (-0.09%)

05:31
09/22/17
09/22
05:31
09/22/17
05:31
Downgrade
Tiffany rating change  »

Tiffany downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 04

    Oct

ASND

Ascendis Pharma

$27.74

-1.55 (-5.29%)

, VSAR

Versartis

$21.60

-0.25 (-1.14%)

05:27
09/22/17
09/22
05:27
09/22/17
05:27
Recommendations
Ascendis Pharma, Versartis analyst commentary  »

Versartis failure bodes…

ASND

Ascendis Pharma

$27.74

-1.55 (-5.29%)

VSAR

Versartis

$21.60

-0.25 (-1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDX

Becton Dickinson

$191.56

-2.44 (-1.26%)

, BCR

C.R. Bard

$317.37

-1.19 (-0.37%)

05:20
09/22/17
09/22
05:20
09/22/17
05:20
Initiation
Becton Dickinson, C.R. Bard initiated  »

Becton Dickinson…

BDX

Becton Dickinson

$191.56

-2.44 (-1.26%)

BCR

C.R. Bard

$317.37

-1.19 (-0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MB

Mindbody

$24.85

0.05 (0.20%)

05:16
09/22/17
09/22
05:16
09/22/17
05:16
Upgrade
Mindbody rating change  »

Mindbody upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPN

Global Payments

$96.34

0.72 (0.75%)

05:14
09/22/17
09/22
05:14
09/22/17
05:14
Initiation
Global Payments initiated  »

Global Payments initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

RMBS

Rambus

$13.34

-0.01 (-0.07%)

05:10
09/22/17
09/22
05:10
09/22/17
05:10
Downgrade
Rambus rating change  »

Rambus downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

EADSY

Airbus

$23.07

0.78 (3.50%)

05:08
09/22/17
09/22
05:08
09/22/17
05:08
Downgrade
Airbus rating change  »

Airbus downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVRA

Savara

$9.47

0.63 (7.13%)

05:06
09/22/17
09/22
05:06
09/22/17
05:06
Initiation
Savara initiated  »

Savara initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANSS

Ansys

$120.82

-2.17 (-1.76%)

05:03
09/22/17
09/22
05:03
09/22/17
05:03
Initiation
Ansys initiated  »

Ansys initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

  • 07

    Nov

VSAR

Versartis

$21.60

-0.25 (-1.14%)

05:00
09/22/17
09/22
05:00
09/22/17
05:00
Downgrade
Versartis rating change  »

Versartis downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEG

PSEG

$46.22

0.99 (2.19%)

04:58
09/22/17
09/22
04:58
09/22/17
04:58
Upgrade
PSEG rating change  »

PSEG upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 05

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.